Department of Ophthalmology Faculty of Medicine, Kagoshima University Graduate School of Medicine and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.
Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):71-8. doi: 10.1007/s00417-011-1777-7. Epub 2011 Aug 19.
The present study was performed to compare the effects of pars plana vitrectomy (PPV) and single intravitreaous triamcinolone acetonide (IVTA) on diabetic macular edema (DME) in paired eyes.
Prospective comparative study on randomized paired-eyes was carried out at two hospitals. Forty eyes of 20 patients with bilateral DME were included. One randomly-selected eye was treated with PPV (PPV group), and the other eye was treated with IVTA (4 mg, IVTA group). The central macular thickness (CMT) measured by optical coherence tomography (OCT) and best-corrected visual acuity (BCVA) were monitored for 12 months after treatment. Changes from baseline and differences between groups were analyzed using a mixed model.
At 1 and 3 months, CMT decreased significantly in the IVTA group compared to baseline (p < 0.0001 both), but CMT then increased gradually and no significant difference was found at 12 months (p = 0.90). In the PPV group, CMT decreased continuously and reached a significant level at 12 months (p < 0.0001). CMT of the IVTA group was significantly less than that of the PPV group at 1 month (p = 0.009); however, there was no significant difference at 3 months. Conversely, CMT was significantly less in the PPV group than in the IVTA group at 12 months (p = 0.0003). The changes of BCVA paralleled those of CMT, but no significant difference was detected between baseline BCVA and any time point.
Despite the short-term improvement, DME recurred 6 months after IVTA, while it remained resolved after PPV. Although this study did not reveal a significant change of BCVA with either treatment, PPV resolved DME more effectively than IVTA at 1 year.
本研究旨在比较玻璃体切割术(PPV)和单次玻璃体内曲安奈德(IVTA)对双眼糖尿病黄斑水肿(DME)的疗效。
在两家医院进行前瞻性随机配对眼比较研究。纳入 20 例双侧 DME 患者的 40 只眼。随机选择一只眼行 PPV(PPV 组),另一只眼行 IVTA(4mg,IVTA 组)治疗。治疗后 12 个月,采用光学相干断层扫描(OCT)测量中心黄斑厚度(CMT)和最佳矫正视力(BCVA)。采用混合模型分析从基线的变化和组间差异。
IVTA 组在 1 个月和 3 个月时 CMT 与基线相比显著降低(均 p < 0.0001),但随后逐渐升高,12 个月时无显著差异(p = 0.90)。PPV 组 CMT 持续下降,12 个月时达到显著水平(p < 0.0001)。IVTA 组 CMT 在 1 个月时显著低于 PPV 组(p = 0.009),但 3 个月时无显著差异。相反,PPV 组在 12 个月时 CMT 显著低于 IVTA 组(p = 0.0003)。BCVA 的变化与 CMT 平行,但基线 BCVA 与任何时间点均无显著差异。
尽管 IVTA 治疗后短期内改善,但 DME 在 6 个月后复发,而 PPV 后则持续缓解。尽管本研究未发现两种治疗方法对 BCVA 有显著变化,但 PPV 在 1 年内比 IVTA 更有效地缓解 DME。